Federal Circuit Vacates Finding Apotex Infringed Drug Delivery Patents

(January 9, 2018, 1:22 PM EST) -- WASHINGTON, D.C. — A Delaware federal judge erred by failing to construe “extended release coating” as the term appears in two drug delivery patents as requiring a continuous outer film, in light of intrinsic evidence, the Federal Circuit U.S. Court of Appeals ruled Jan. 4 (Aptalis Pharmatech Inc., et al. v. Apotex Inc., et al., No. 17-1344, Fed. Cir., 2018 U.S. App. LEXIS 201)....

Attached Documents

Related Sections